Una candidatura completa in un minuto
Curriculum e lettera di presentazione personalizzati, pronti da inviare.
Eli Lilly and Company in Indianapolis seeks a Senior Director of External Innovation within Neuroscience to own strategy and execution for external partnerships, leading projects from opportunity identification through due diligence to deal close. You will combine scientific acumen with business judgment and mentor junior colleagues.
You will interact with senior management, translate priorities into search themes, and oversee cross-functional collaboration across Therapeutic areas to advance
At Lilly, the work is demanding because patients are waiting. We unite caring with discovery to help make life better for people around the world, knowing that every decision, every detail, and every day matters. Headquartered in Indianapolis, Indiana, our over 50,000 employees around the globe take on complex challenges to discover and deliver life-changing medicines, strengthen how health is understood and managed, and support the communities we serve. This is hard, urgent, selfless work—but it's work worth doing.
External Innovation is a critical growth lever for Lilly's portfolio strategy and long-term company success. As internal pipelines are increasingly complemented by external science, the identification, rigorous evaluation, and disciplined advancement of external opportunities represent a substantial and growing investment across the enterprise - one that materially shapes Lilly's ability to deliver breakthrough medicines. Roughly half of Lilly's new product launches over the past decade were enabled by external innovation.
The Senior Director, External Innovation owns external innovation strategy and execution for one or more dedicated therapeutic or disease area(s) within Neuroscience (e.g., Neurodegeneration, Pain, Psychiatry/Psychedelics, or Sleep-Awake). This role independently leads partnering projects from opportunity identification through scientific due diligence and recommendation to deal completion, translates strategic theses into deal constructs, and serves as the scientific point of contact for partners, combining deep scientific/technical judgment with strong business and deal-structuring acumen. This role may mentor or directly supervise more junior External Innovation colleagues.
This role’s responsibilities center on three core areas — Search (identify partners and lead early assessment and triage of opportunities; serve as a key contact for partners), Evaluate (assess opportunities with rigorous scientific, technical and business judgment to identify key risks and inform decisions; lead pre-diligence and own scientific due diligence) and Advance (build organizational conviction and stakeholder alignment so that priority opportunities progress to deal completion and are set up to succeed after close).
Own external innovation strategy and approach for the assigned therapeutic/disease area(s) within Neuroscience; interact independently with senior management to understand internal portfolio and strategic priorities, develop external strategy, and jointly prioritize external opportunities; translate these priorities into explicit search themes, landscapes and go/no-go criteria.
Identify and search external innovation and/or collaboration opportunities including but not limited to assets, portfolios and platforms, through systematic landscape screens, scientific and partnering conferences, and an active network across biotech, academia, venture capital and pharma; identify partners and lead early assessment of opportunities and triage.
Lead and be responsible for initial technical evaluations for the designated disease area, including leveraging therapeutic area-specific and cross-functional expertise where appropriate. Own the designated disease area’s in-depth scientific due diligence, applying scientific, technical, and business judgment to identify the critical diligence questions, key opportunities and risks; resolve conflicts and align stakeholders. Independently lead partnering projects — including all partner interactions, scientific due diligence, consolidation of feedback into a clear written recommendation (advance, hold or decline, with rationale), preparation of management decks, and collaboration with Corporate Business Development on evolution of deal structure and progression to close. Provide timely, constructive scientific feedback to potential partners at each stage of review, nurturing long-term relationships in parallel with evaluations so that Lilly is regarded as a partner of choice.
Translate the scientific and strategic thesis into an initial deal construct - including structure, scope, and value rationale, with business terms aligned to key scientific and clinical inflection points - and lead early commercial conversations with partners to test and shape it before formalizing the deal team. Build organizational conviction behind priority opportunities through effective stakeholder management across therapeutic area, Business Unit and Corporate Business Development leadership, ensuring alignment to strategic needs as opportunities move toward deal completion. Partner effectively with cross-functional colleagues throughout the deal lifecycle - including Due Diligence, Corporate Business Development (Transactions), Alliance & Innovation Management, Legal and Intellectual Property, and the relevant Lilly Research Laboratories and therapeutic area functions - to ensure opportunities are properly vetted, negotiated, and integrated post-close; remain the scientific point of contact through hand-over to the receiving team.
Represent external innovation for the assigned area(s) in relevant lead team meetings; contribute to the Neuroscience external innovation deal-flow review with therapeutic area and Corporate Business Development/External Innovation stakeholders; own selection of topics and presentations on the assigned area(s) for senior management forums. Maintain deep scientific knowledge of internal portfolio projects, external opportunities, and the competitive landscape for the assigned area(s), spanning discovery, clinical development, and platforms; actively monitor relevant external preclinical- and clinical-stage assets and competitor data readouts. Represent Lilly's strategic and external innovation priorities for the assigned area(s) at external meetings across a broad range of partners; participate in industry roundtables and invited presentations; maintain strong external networks across biotech, venture capital, and pharma.
Mentor and support junior External Innovation colleagues on deals within the area of interest — reviewing management decks, advising on deal structure, and helping guide partner interactions.